Bexsero, meningitis B vaccine vaccination campaign results released
Novartis has announced the initial results of a large-scale vaccination campaign with Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) to help protect against meningitis B within the Saguenay-Lac-Saint-Jean More...
Novartis seeks FDA approval for meningitis B vaccine, Bexsero
Basel, June 17, 2014 – Novartis announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent More...
Hartt School senior, Patrick Chittenden, died from meningococcal meningitis: University of Hartford official
Bacterial meningitis has been confirmed as the cause of death of a senior at the Hartt School at the University of Hartford who died late last week, according to a university official Saturday. In a health advisory More...
Princeton researcher to conduct meningitis B vaccine study
Princeton University received attention back in March 2013 following eight cases of infection from serogroup B Neisseria meningitidis bacteria, and a total of nine cases associated with the university. To prevent More...
Bexsero, meningitis B vaccine, receives FDA Breakthrough Therapy designation
PRESS RELEASE Novartis announced today that Bexsero® (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) has received a Breakthrough Therapy designation from the United States Food and Drug Administration More...
Princeton meningitis strain confirmed in Drexel fatal case
Eight days ago, the community at Drexel University in Philadelphia was shocked by the sudden death of 19-year-old sophomore Stephanie Ross. At the time it was suspected that the cause of her dearth was bacterial More...
Meningococcal meningitis group B confirmed in Drexel University student fatality
In a follow-up to a report Tuesday, Philadelphia health officials confirm that the strain of bacterial meningitis implicated in the death of Drexel University sophomore, 19-year-old Stephanie Ross was serogroup More...
Princeton student’s possible adverse reaction to Bexsero: What is Rhabdomyolysis?
Just one week after Princeton University administered the second dose of the unlicensed meningococcal meningitis vaccine, Bexsero, and the week the University of California, Santa Barbara (UCSB) began giving the More...
UC Santa Barbara will be offering the meningitis B vaccine, Bexsero, starting Feb. 24
In a follow-up to a story one month ago, The University of California, Santa Barbara (UCSB), who has experienced four cases of meningococcal meningitis group B during a three week time frame in Nov. 2013, will More...
The Top 10 Infectious Disease and Outbreak News stories of 2013
2013 was a year full of impactful infectious disease stories with outbreaks of diseases not before seen in humans, diseases seen in new parts of the planet and miracle stories of survivors. Drugs not approved in More...
UCSB: CDC will make meningitis B vaccine available ‘if the circumstances of this outbreak warrant its use’
Just as the vaccine clinics at Princeton opened this Monday to immunize undergraduates and select others against the outbreak strain of Neisseria meningitidis serogroup B, the University of California, Santa Barbara More...
Princeton inoculates 91 percent of eligible University members
After four days of a vaccine clinic at the Frist Campus Center at Princeton University, school officials say that 5,268 eligible individuals, or 91 percent of the University community received the first dose of More...
Princeton vaccinates 4,361 with Bexsero with one clinic day left
Princeton University said Wednesday that more than 4,300 people received the first dose of the two-dose series of the meningococcal serogroup B vaccine after three days of clinic operations. Neisseria meningitidisImage/CDC As More...
Princeton vaccinates hundreds on first day with meningitis B vaccine, Bexsero
According to Princeton University, as of 4:30 p.m today, 1,261 individuals were vaccinated to help protect against meningococcal disease caused by serogroup B bacteria. Neisseria meningitidisImage/CDC In a More...
Princeton to host ‘open forums’ about meningitis and the vaccination
Princeton University announced today that they will be holding open forums Thursday and Friday (Dec. 5 and 6) for faculty, staff and students who want to learn more about the meningococcal vaccine and bacterial More...
UC Santa Barbara freshman, Aaron Loy, has feet amputated due to meningococcal disease
The University of California, Santa Barbara meningitis outbreak affected three students in recent weeks, in which two have recovered and returned to school. However, one student, a lacrosse player from Carlsbad, More...
CDC expert: Use of unlicensed vaccine, Bexsero, ‘highly unusual’
During a telebriefing yesterday with CDC pediatrician and meningitis expert, Dr Amanda Cohn, a couple of key questions were answered concerning the Novartis meningitis vaccine, Bexsero. Neisseria meningitidisImage/CDC When More...
CDC expert talks about Princeton, UC Santa Barbara meningitis B cases
In response to the 11 Neisseria meningitis serogroup B cases reported between Princeton University in New Jersey and the University of California, Santa Barbara, CDC meningitis expert, Dr Amanda Cohn addressed the More...
Princeton announces dates for receiving meningitis B vaccine
The New Jersey university, which has experienced eight cases of serogroup B meningococcal disease since March, has announced the dates they will be administering the vaccine that helps protect against meningococcal More...
What is Bexsero? How common is meningococcal disease serogroup B?
With the eighth case of meningococcal meningitis confirmed at Princeton University yesterday, and at least seven confirmed as Neisseria meningitis serotype B (MenB) with the most recent still pending, health officials More...
